These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32408197)

  • 1. B cell depletion in murine lupus using cytotoxic T lymphocytes in vivo: Feasibility and benefit.
    Soloviova K; Puliaeva I; Puliaiev M; Puliaev R; Via CS
    Cell Immunol; 2020 Jul; 353():104117. PubMed ID: 32408197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.
    Nguyen V; Rus H; Chen C; Rus V
    J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.
    Haas KM; Watanabe R; Matsushita T; Nakashima H; Ishiura N; Okochi H; Fujimoto M; Tedder TF
    J Immunol; 2010 May; 184(9):4789-800. PubMed ID: 20368280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gr-1(high) CD11b+ cells suppress B cell differentiation and lupus-like disease in lupus-prone male mice.
    Trigunaite A; Khan A; Der E; Song A; Varikuti S; Jørgensen TN
    Arthritis Rheum; 2013 Sep; 65(9):2392-402. PubMed ID: 23754362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus.
    Puliaev R; Puliaeva I; Welniak LA; Ryan AE; Haas M; Murphy WJ; Via CS
    J Immunol; 2008 Jul; 181(1):47-61. PubMed ID: 18566369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel function of B lymphocytes from normal mice to suppress autoimmunity in (NZB x NZW)F1 mice.
    Ono S; Shao D; Yamada S; Yang Y; Yamashita M; Hamaoka T
    Immunology; 2000 May; 100(1):99-109. PubMed ID: 10809965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
    Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
    Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.
    Reininger L; Winkler TH; Kalberer CP; Jourdan M; Melchers F; Rolink AG
    J Exp Med; 1996 Sep; 184(3):853-61. PubMed ID: 9064345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the gene linked to the T cell receptor beta chain gene complex of NZW mice to the autoimmunity of (NZB x NZW)F1 mice.
    Hirose S; Tokushige K; Kinoshita K; Nozawa S; Saito J; Nishimura H; Shirai T
    Eur J Immunol; 1991 Mar; 21(3):823-6. PubMed ID: 1826267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid dendritic cells from parent strains of the NZB/W F1 lupus mouse contribute different characteristics to autoimmune propensity.
    Zhan Y; Kong I; Chopin M; Macri C; Zhang JG; Xie J; Nutt SL; O'Keeffe M; Hawkins ED; Morand EF; Lew AM
    Immunol Cell Biol; 2020 Mar; 98(3):203-214. PubMed ID: 31916630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The parent-into-F1 murine model in the study of lupus-like autoimmunity and CD8 cytotoxic T lymphocyte function.
    Soloviova K; Puliaiev M; Foster A; Via CS
    Methods Mol Biol; 2012; 900():253-70. PubMed ID: 22933073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.
    Zhang M; Yu G; Chan B; Pearson JT; Rathanaswami P; Delaney J; Ching Lim A; Babcook J; Hsu H; Gavin MA
    Arthritis Rheumatol; 2015 Oct; 67(10):2723-31. PubMed ID: 26097207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class-specific regulation of anti-DNA antibody synthesis and the age-associated changes in (NZB x NZW)F1 hybrid mice.
    Sekigawa I; Okada T; Noguchi K; Ueda G; Hirose S; Sato H; Shirai T
    J Immunol; 1987 May; 138(9):2890-5. PubMed ID: 2952727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
    Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
    Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of the parent-into-F1 model for human lupus pathogenesis: roles for cytotoxic T lymphocytes and viral pathogens.
    Via CS
    Curr Opin Rheumatol; 2010 Sep; 22(5):493-8. PubMed ID: 20485174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus.
    Decker DA; Grant C; Oh L; Becker PM; Young D; Jordan S
    Lupus; 2014 Jul; 23(8):802-12. PubMed ID: 24759631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
    McMurray RW; Elbourne KB; Lagoo A; Lal S
    J Rheumatol; 1998 Dec; 25(12):2364-70. PubMed ID: 9858431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent responsiveness to interleukin-6 in B lymphocytes from a systemic lupus erythematosus-prone (NZB x NZW)F1 hybrid.
    Alarcón-Riquelme ME; Möller G; Fernández C
    Clin Immunol Immunopathol; 1992 Mar; 62(3):264-9. PubMed ID: 1541052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.
    Monneaux F; Dumortier H; Steiner G; Briand JP; Muller S
    Int Immunol; 2001 Sep; 13(9):1155-63. PubMed ID: 11526096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW)F1 mouse model of systemic lupus erythematosus.
    Ebling FM; Tsao BP; Singh RR; Sercarz E; Hahn BH
    Arthritis Rheum; 1993 Mar; 36(3):355-64. PubMed ID: 7680861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.